Melanocortin receptor antagonists and agonists
US6054556A · kind A · utility
73Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 28, 1997 |
| Grant date | Apr 25, 2000 |
| Priority date | — |
| Expiry date | Nov 28, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/27
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Cyclic lactam peptides are disclosed which inhibit at various levels of antagonism the melanocortin 1 receptor (MC1R), melanocortin 3 receptor (MC3R), melanocortin 4 receptor (MC4R), and Melanocortin 4 receptor (MC5R).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.